Drug
Curate AI
Curate AI: highest development phase Phase 1/2, developed by Natera. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Natera
Trials
| Drug | Phase | Indication |
|---|---|---|
| CURATE.AI NCT05175235 | Phase 1/2 | Solid Tumor |
Latest
No recent events.
Follow Curate AI on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.